Concretely, male RA patients of Low Hb group experience significantly worse survival outcomes (P < 0.0001), while the female patients of Low Hb group, although having relatively poor survival outcomes, show no statistically significant difference (P = 0.13). This evidence concerns the gene GSTM1 and rheumatoid arthritis.